在初级穿皮冠状动脉干预中,什么是最佳的辅助再注血策略?
Nicholas Curzen1, Paul A Gurbel, Aung Myat
1Wessex Cardiothoracic Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK. nick.curzen@uhs.nhs.uk
Lancet (London, England)
|August 20, 2013
概括
血小板是急性心肌梗塞 (STEMI) 的关键. 在STEMI患者的初级皮肤冠状动脉干预后,最佳的抗血栓治疗对于改善结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 血管生物学 血管生物学
背景情况:
- 急性ST段升高心肌梗塞 (STEMI) 是由血栓形成驱动的关键心血管事件.
- 血小板在STEMI的病理生理学中发挥着中心作用,启动和放大血栓和炎症过程.
- 这些过程包括闭塞性血栓形成,血管炎症,血管活性,胀和微血管阻塞.
研究的目的:
- 审查当前的药理和机械辅助疗法,以在STEMI中进行再注射.
- 确定接受初级皮肤穿冠状动脉干预 (PCI) 的患者治疗的最佳组合.
主要方法:
- 对现有药理和机械疗法的文献综述.
- 分析血小板激活,脱粒和聚合在STEMI中的作用.
- 评估辅助治疗策略与初级PCI结合使用.
主要成果:
- 血小板激活对STEMI的发展和进展至关重要.
- 有效的抗血栓治疗对于优化PCI后的结果至关重要.
- 目前的治疗策略旨在抑制血小板功能和血栓形成.
结论:
- 对STEMI患者来说,迅速,强效和可预测的抗血栓治疗是必要的.
- 辅助疗法与主要PCI相结合的最佳组合需要进一步研究.
- 了解血小板的作用指导着改进的STEMI治疗方案的开发.
相关概念视频
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...


